Stereotactic radiotherapy (SRT) for oligometastatic (OM) relapse and metastatic oligoprogression (OP) in renal cell carcinoma (RCC) patients (pts): A study of the GETUG group.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e16105-e16105 ◽  
Author(s):  
Emmanuel Meyer ◽  
Dinu Stefan ◽  
David Pasquier ◽  
Guillemette Bernadou ◽  
Gilles Calais ◽  
...  
2021 ◽  
Vol 28 (3) ◽  
pp. 1744-1750
Author(s):  
Laura Burgess ◽  
Marissa Keenan ◽  
Alan Liang Zhou ◽  
Kiefer Lypka ◽  
Delvina Hasimja Saraqini ◽  
...  

Approximately 20% of renal cell carcinoma (RCC) is diagnosed because of paraneoplastic manifestations. RCC has been associated with a large variety of paraneoplastic syndromes (PNS), but it is rarely associated with PNS vasculitis. We present a case of a previously healthy male who presented with systemic vasculitis; bitemporal headaches, diplopia, polyarthritis, palpable purpura, tongue lesion, peri-orbital edema, scleritis, chondritis and constitutional symptoms. He was subsequently found to have oligometastatic RCC. Both his primary lesion and site of oligometastasis were treated with stereotactic radiotherapy (SBRT) and resulted in the resolution of his vasculitis, as well as sustained oncologic response. This is the first case to demonstrate that effective sustained treatment for PNS vasculitis due to oligometastatic RCC is possible with SBRT.


2012 ◽  
Vol 110 (11b) ◽  
pp. E737-E743 ◽  
Author(s):  
Shankar Siva ◽  
Daniel Pham ◽  
Suki Gill ◽  
Niall M. Corcoran ◽  
Farshad Foroudi

2014 ◽  
Vol 7 (1) ◽  
Author(s):  
Hiroshi Onishi ◽  
Tomonori Kawasaki ◽  
Hidenori Zakoji ◽  
Takashi Yoshida ◽  
Takafumi Komiyama ◽  
...  

2019 ◽  
Vol 18 ◽  
pp. 104-112 ◽  
Author(s):  
Alexander Rühle ◽  
Nicolaus Andratschke ◽  
Shankar Siva ◽  
Matthias Guckenberger

Sign in / Sign up

Export Citation Format

Share Document